About the Journal

Since its launch in June 2023, the Swiss Journal of Radiology and Nuclear Medicine (SJORANM) has aimed to be more than simply another imaging journal. Created by experienced specialists in radiology, nuclear medicine, and clinical imaging, the journal provides a platform where scientific integrity, intellectual independence, and clinical relevance are paramount.

SJORANM is committed to evidence-based medicine and rigorous scientific evaluation. Manuscripts are assessed according to their scientific merit, methodological quality, originality, and relevance to clinical practice, irrespective of the authors' nationality, institutional affiliation, or personal viewpoints.

The journal covers the full spectrum of diagnostic and therapeutic imaging, including radiology, neuroradiology, nuclear medicine, hybrid imaging, interventional procedures, artificial intelligence, image-guided therapies, and emerging imaging technologies.

In addition, SJORANM welcomes submissions from related medical disciplines whenever imaging plays a significant role in diagnosis, disease monitoring, treatment planning, or outcome assessment.

The journal publishes original research articles, reviews, case reports, technical innovations, educational contributions, commentaries, and expert perspectives that contribute to the advancement of imaging-driven medicine and patient care.

Mission

SJORANM publishes meaningful and innovative scientific work in radiology, nuclear medicine, medical imaging, and imaging-driven medicine with the aim of contributing to better diagnosis, treatment planning, disease monitoring, and patient care.

Vision

SJORANM aims to become a leading Swiss and internationally visible journal for relevant, actionable, and clinically meaningful discoveries in medical imaging.

The journal seeks to provide physicians, researchers, and healthcare professionals with reliable scientific information that supports medical progress, improves clinical decision-making, and ultimately contributes to reducing the burden of disease.

SJORANM is an online journal with a regular publication schedule throughout the year.

The journal typically publishes monthly issues and aims to release at least nine issues annually.

Additional special issues, thematic collections, conference proceedings, or supplementary publications may be released when appropriate.

All accepted articles are published online and remain permanently accessible through the journal's Diamond Open Access model.

SJORANM follows a Diamond Open Access publishing model.

This means that neither authors nor readers are charged for participation in scientific communication.

• No article processing charges (APCs).
• No submission fees.
• No publication fees.
• No subscription fees.
• Immediate and unrestricted access to all published content.

All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits sharing, distribution, adaptation, and reuse of published material, provided appropriate credit is given to the original authors.

Authors retain copyright of their work while granting SJORANM the right of first publication.

The journal believes that unrestricted access to scientific knowledge promotes international collaboration, scientific progress, and equitable access to medical information.

SJORANM operates a double-anonymized peer review process designed to ensure scientific quality, fairness, and editorial independence.

During peer review, the identities of authors and reviewers remain concealed from one another. Editors are aware of both author and reviewer identities in order to manage the review process appropriately.

Following an initial editorial assessment, manuscripts considered suitable for the journal are assigned to qualified reviewers with relevant subject expertise. Reviewer evaluations assist the editors in assessing scientific quality, methodological rigor, originality, and clinical relevance.

Editorial decisions are based exclusively on scientific merit and are independent of financial, institutional, political, or commercial considerations.

SJORANM is committed to maintaining a constructive, objective, and ethical peer review process that supports authors while safeguarding scientific standards.

Detailed information regarding peer review procedures, reviewer responsibilities, appeals, and editorial decision-making is available in the journal's dedicated Peer Review Policy.

SJORANM is committed to maintaining the highest standards of publication ethics, research integrity, and responsible scientific conduct.

The journal follows internationally recognized principles and recommendations issued by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and other relevant organizations supporting ethical scientific publishing.

Authors are expected to ensure that submitted work is original, scientifically accurate, appropriately referenced, and conducted in accordance with applicable ethical and regulatory requirements.

The journal does not tolerate plagiarism, data fabrication, data falsification, image manipulation, inappropriate authorship practices, duplicate publication, citation manipulation, or other forms of scientific misconduct.

Research involving human participants or animals must comply with applicable ethical standards, institutional requirements, and international guidelines. Where required, appropriate ethics committee approval and informed consent must be documented.

The use of artificial intelligence (AI) tools in research preparation or manuscript development must be disclosed transparently. AI systems do not qualify for authorship.

Allegations of research misconduct are investigated according to established editorial procedures and relevant COPE guidance.

SJORANM is committed to transparency regarding relationships, activities, and interests that could influence, or be perceived to influence, scientific judgment and editorial decision-making.

All authors are required to disclose any financial, professional, institutional, personal, or other relationships that may represent a potential conflict of interest in connection with their submitted work.

Peer reviewers and editors must recuse themselves from the evaluation of manuscripts whenever a conflict of interest could compromise, or reasonably appear to compromise, objectivity and impartiality.

Manuscripts submitted by members of the Editorial Board, editors, or individuals with editorial responsibilities are handled independently by editors without conflicts of interest.

When appropriate, conflict of interest disclosures are published alongside accepted articles to ensure transparency for readers and the scientific community.

The journal believes that transparent disclosure of potential conflicts of interest is essential for maintaining trust, credibility, and scientific integrity.

SJORANM supports international standards that improve the transparency, discoverability, accessibility, and long-term preservation of scientific research.

Authors are encouraged to provide their ORCID iD (Open Researcher and Contributor ID) to facilitate accurate attribution of scholarly work and to enhance the visibility of their research contributions.

Wherever ethically and legally feasible, authors are encouraged to make the data, materials, software, and supporting information underlying their research available to readers through appropriate repositories or supplementary materials.

The journal supports principles of research transparency, reproducibility, and responsible data sharing in accordance with accepted scientific standards and applicable regulations.

To ensure long-term accessibility of published content, SJORANM is committed to the preservation of the scholarly record through recognized digital preservation and archiving mechanisms.

The journal continuously evaluates opportunities to strengthen the discoverability, interoperability, preservation, and long-term accessibility of its published content.

SJORANM is committed to fair, transparent, and accountable editorial processes.

Authors who believe that an editorial decision was based on a misunderstanding, procedural irregularity, or factual error may submit a formal appeal for reconsideration. Appeals are reviewed independently and objectively.

Complaints concerning editorial procedures, publication ethics, reviewer conduct, or journal operations are taken seriously and will be investigated in accordance with established editorial procedures and relevant COPE guidance where applicable.

The journal is committed to maintaining the integrity of the scholarly record. When significant errors, omissions, or inaccuracies are identified, appropriate actions may include corrections, expressions of concern, or retractions.

Decisions regarding corrections and retractions are based on the available evidence and are guided by principles of transparency, fairness, and scientific integrity.

SJORANM believes that responsible scientific publishing requires not only rigorous peer review, but also transparent mechanisms for addressing concerns and correcting the scientific record when necessary.

Editorial Office

Swiss Journal of Radiology and Nuclear Medicine (SJORANM)
SJORANM GmbH
Blegistrasse 9
CH-6340 Baar
Switzerland

Email: admin@sjoranm.com

SJORANM GmbH is a legal entity registered under Swiss law with its registered office in Baar, Switzerland.

Swiss Commercial Register Number: CHE-320.280.011

Swiss Journal of Radiology and Nuclear Medicine® is a registered European Union Trade Mark.